Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

An overview of the Peptide Synthesis Market

The peptide synthesis market is projected to secure a valuation of US$ 520.0 million in 2023 and is rising to US$ 1.1 billion by 2033. The market is predicted at a CAGR of 8% during the forecast period.

Peptide Synthesis Market – Driving Factors

  • The rising number of pediatric patients, metabolic disorders, and growing demand for low-cost and effective drugs drive market growth.
  • The adoption of peptide synthesis is rising due to high specificity, broad chemicals, low toxicity, and higher biological activity.
  • The growing popularity of pharmacological components to develop medication is increasing the demand for peptide synthesis.
  • Rising chronic diseases, including oncology, obesity, and diabetes, are expanding the market.
  • The adoption of peptide synthesis is rising significantly for treating neurological illnesses and cardiovascular and renal failure.

Increasing Medication Issues Decline Market Growth

Rising chemical-produced medications and regulatory issues are the factors that may restrain market growth. The European Medicines Agency and Food and Drug Administration are also at odds in regulating the approval of medications based on the peptide. The lack of consistent rules and difficulty in permitting therapeutic peptides limit market growth.

How do Peptide Synthesis Manufacturers Drive Market Opportunities?

Advanced medicine and limited side effects increase the demand for peptide synthesis and market opportunities during the forecast period. The growing investment and key healthcare manufacturers pushing the investment in personalized medicine are driving market expansion. Growing technology of automated injection of various chemicals, such as membrane enhanced and ligand synthesis, is increasing the adoption of peptide synthesis.

Growing healthcare infrastructure and improvements in medications are boosting market opportunities. Manufacturers are advancing customized medicine, and individualized therapy for patients is further increasing market opportunities. The development of proteomic analysis and methods of determining molecular profiles greatly contribute to expanding the market growth.

The adoption of proteomics to clarify pathomechanisms illness is propelling the market size. The European Union scientist announced the development of user-friendly electrochemical customized peptide synthesis in the ElectroMed project, a technology to detect the interaction between immune receptors and short peptides. This customized peptide synthesis is typically based on a microfluidic multiplexing system.

Attributes Details
Market CAGR (2023 to 2033) 8%
Market Valuation (2023) US$ 520 million
Market Valuation (2033) US$ 1.1 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Peptide Synthesis Market, 2017 to 2022 Historical Sales, Compared to 2023 to 2033 Future Outlook

According to Future Market Insights, the global peptide synthesis market is predicted at a healthy 8% CAGR during the forecast period. Historically, the market registered a CAGR of 11.5% between 2017 and 2022.

  • Short Term (2023 to 2026): The increasing demand for peptide synthesis due to the growing metabolic disorders and low-cost treatments.
  • Medium Term (2026 to 2029): The increasing biotech sector, advanced therapy, and investment in personalized medicine are driving market expansion.
  • Long Term (2029 to 2033): Growing automated injection technology and the development of proteomics are increasing market opportunities.

The market is estimated to reach US$ 1.1 billion during the forecast period. Historically, the market stood at US$ 460.0 million from 2017 to 2022.

Comparative Analysis of Adjacent Markets

Peptide Synthesis Market:

Attributes Peptide Synthesis Market
CAGR (2023 to 2033) 8%
Value (2023) US$ 520.0 million
Value (2033) US$ 1.1 billion
Trends The increasing biotech sector, advanced therapy, and investment in personalized medicine are driving market expansion.
Opportunities Increasing automated injection technology and development of proteomics driving market opportunities.

Peptide Therapeutics Market:

Attributes Peptide Therapeutics Market
CAGR (2023 to 2033) 8%
Value (2023) US$ 40.49 billion
Value (2033) US$ 87.41 billion
Trends Growing demand for immune peptides and developed infrastructure.
Opportunities Governments initiative, growing advanced therapy, and research and development activities.

Custom Peptide Synthesis Services Market:

Attributes Custom Peptide Synthesis Services Market
CAGR (2023 to 2033) 7%
Value (2023) US$ 571.41 million
Value (2033) US$ 1,124.05 million
Trends Growing research activities and investment in peptide synthesis.
Opportunities Rising healthcare services and research activities to design drugs and vaccines
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Top Two Segments in the Market

Segments Product  and Services
Top Category Reagents
Historic CAGR 11.4%
Forecast CAGR 7.8%
Segments End Use
Top Category Pharmaceuticals & Biotechnology Companies
Historic CAGR 11.1%
Forecast CAGR 7.6%

Which Category Leads the Product and Services Segment?

Based on the product and services segment, the reagents category holds a maximum CAGR of 7.8% during the forecast period. The adoption of reagents widely in laboratories, pharmaceutical manufacturing, and research & development activities is driving the market growth.

Apart from reagents, coupling agents are also widely used by various chemical laboratories to identify or research a particular substance. These growing demand factors are flourishing the market expansion. Historically, the reagents captured a CAGR of 11.4% between 2017 and 2022.

Which Category is Traced in the Technology Segment?

Based on technology, the segment is divided into solid-phase peptide synthesis, solution-phase peptide synthesis, and membrane-enhanced peptide synthesis technology. Pharmaceuticals & biotechnology sectors use different technology to develop a certain product type. Therefore, chemical synthesis is the commonly used process for peptide production in these industries.

This process has influenced the adoption of enzymatic technology. Though, the changing environment and manufacturing caps on industries slow down the growth of this segment. The process of chemical synthesis triggers pollution and environmental risks.

Who is Leading the End Use Segment?

Based on end use, there are several industries like CDMOs & CROs, pharmaceuticals & biotechnology, academics & research institutions, and others. Pharmaceuticals and biotechnology are leading the segment by securing a CAGR of 7.6% during the forecast period. The adoption of peptide synthesis for the development of therapeutic in pharmaceuticals & biotechnology is bolstering the market growth.

The growing demand for drugs and vaccines with peptide synthesis is driving the pharmaceutical sector. For instance, AstraZeneca launched new advanced peptide therapy and next-generation medicine through research and development programs. FDA-approved Rybelsus tablets for diabetes type 2 patients. Historically, pharmaceuticals & biotechnology secured a CAGR of 11.1% between 2017 and 2020.

Top Countries Data Table Mentioned Below

Countries United States
CAGR (2017 to 2022) 13.5%
CAGR (2023 to 2023) 7.8%
Valuation (2023 to 2033) US$ 398.6 million
Countries United Kingdom
CAGR (2017 to 2022) 12.5%
CAGR (2023 to 2023) 7.1%
Valuation (2023 to 2033) US$ 47.3 million
Countries China
CAGR (2017 to 2022) 13.1%
CAGR (2023 to 2023) 7.4%
Valuation (2023 to 2033) US$ 80.7 million
Countries Japan
CAGR (2017 to 2022) 12%
CAGR (2023 to 2023) 6.5%
Valuation (2023 to 2033) US$ 66 million
Countries South Korea
CAGR (2017 to 2022) 11.1%
CAGR (2023 to 2023) 6%
Valuation (2023 to 2033) US$ 39.6 million

Growing Chronic Diseases Drive the United States Market

The United States dominates the global market by securing a CAGR of 7.8% with a valuation of US$ 398.6 million during the forecast period. The rise in chronic patients adopting peptide-based vaccines and drugs propels the United States market. In 2022, according to the American Cancer Society, around 1.9 million new cancer cases grew in the United States. Cancer is a prior deadly disease after a heart attack in the United States.

Increasing rates of diabetes patients, inactive lifestyles, and obesity are fueling the United States peptide synthesis market. In addition, the development of modern drugs and increasing government investment are expanding the United States market. Historically, the United States secured a CAGR of 13.5% between 2017 and 2022.

Research & Development Activities Upsurge the United Kingdom Market

The United Kingdom captured a CAGR of 7.1% with a valuation of US$ 47.3 million during the forecast period. Developing advanced chemical and organic peptides with a high investment in research and development activities is expanding the United States market. In addition, the growing risk of chronic diseases and the presence of the biochemical industry is surging the United States peptide synthesis market.

The rising urbanization, healthcare infrastructure, and manufacturing industry are expanding the market. Historically, the United Kingdom secured a CAGR of 12.5% between 2017 and 2020.

Increasing Biotech Industry Boosts China Market

China is contributing a CAGR of 7.4% with a valuation of US$ 80.7 million during the forecast period. Increasing research and development investment and the biotech sector are flourishing in China's peptide synthesis market growth. In addition, rising demand for the minimal cost of raw materials and the adoption of advanced therapy is further increasing the China market expansion.

Lack of proper diet, a sedentary lifestyle, and low physical activities result in chronic diseases, increasing the demand for peptide synthesis. Moreover, the present prominent players and the development of new technologies in peptide synthesis are driving China market. Historically, China secured a CAGR of 13.1% between 2017 and 2020.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

The multiple established companies and the presence of key players consolidate the market. In addition, due to the modernization of medical research and development projects and rising pharmaceutical manufacturing, the key competitors focus on providing effective products and services.

By adopting several marketing tactics and deep market research, the market players are increasing the sales of peptide synthesis products. Their marketing tactics are mergers, acquisitions, collaborations, and partnerships.

Recent Developments in the Market:

  • On the recent Innovation of Greener Technology in slid-phase peptide synthesis, Novo Nordisk and Bachem Holding AG announced their partnership to replace N-dimethylformamide and reprotoxic.
  • The United States-based Thermo Fisher Scientific has recently announced its biopharmaceutical research laboratories. These laboratories perform high throughput and liquid chromatography.
  • In May 2022, Biohaven Pharmaceuticals and Pfizer Inc announced their agreement to manufacture advanced therapy for dual-acting migraine to treat patients and prevent episodic migraine.
  • In May 2022, LOTTE Corporation acquired Bristol Myers to grow New York-based plant production by adopting novel biologics.
  • In February 2022, Plexium and Amgen announced their collaboration to generate protein degradation therapeutics and molecular glue therapeutics.

Other Prominent Players Operating in the Market are

  • GenScript Biotech Corporation
  • Bachem Holding AG
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Kaneka Corporation

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ billion for Value
Key Countries Covered United States, Canada, Germany, United Kingdom., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, South Africa, and Türkiye
Key Segments Covered
  • Product and Services
  • Technology
  • End Use
  • Region
Key Companies Profiled
  • GenScript Biotech Corporation
  • Bachem Holding AG
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Kaneka Corporation
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Peptide Synthesis Market by Category

By Product and Services:

  • Reagents
  • Equipment
  • Services

By Technology:

  • Solid-phase peptide Synthesis
  • Solution-phase Peptide Synthesis
  • Hybrid & Recombinant Technology

By End Use:

  • Pharmaceuticals & Biotechnology Companies
  • CDMOs & CROs
  • Academics & Research Institutes

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa (MEA)

Frequently Asked Questions

What is the market value in 2023?

The market in 2023 is valued at US$ 520.0 million.

What is the growth rate of the market until 2033?

By 2033, the market will expand at a 8% CAGR.

What is the market value for 2033?

By 2033, the market will reach US$ 1.1 billion.

What was the market’s historical performance?

From 2018 to 2022, the global market exhibited a 11.5% CAGR.

Who are the Key Peptide Synthesis Market Players?

Merck KGaA, Kaneka Corporation

Table of Content

1. Executive Summary | Peptide Synthesis Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global   Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product and Service

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product and Service, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product and Service, 2023 to 2033

        5.3.1. Reagents

        5.3.2. Equipment

        5.3.3. Services

    5.4. Y-o-Y Growth Trend Analysis By Product and Service, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product and Service, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033

        6.3.1. Solid-Phase Peptide Synthesis

        6.3.2. Solution-Phase Peptide Synthesis

        6.3.3. Hybrid & Recombinant Technology

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End Use 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End Use , 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use , 2023 to 2033

        7.3.1. Pharmaceuticals & Biotechnology Companies

        7.3.2. CDMOs & CROs

        7.3.3. Academics & Research Institutes

    7.4. Y-o-Y Growth Trend Analysis By End Use , 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By End Use , 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product and Service

        9.2.3. By Technology

        9.2.4. By End Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product and Service

        9.3.3. By Technology

        9.3.4. By End Use

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product and Service

        10.2.3. By Technology

        10.2.4. By End Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product and Service

        10.3.3. By Technology

        10.3.4. By End Use

    10.4. Key Takeaways

11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Product and Service

        11.2.3. By Technology

        11.2.4. By End Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product and Service

        11.3.3. By Technology

        11.3.4. By End Use

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. Thailand

            12.2.1.5. Singapore

            12.2.1.6. Australia

            12.2.1.7. Rest of Asia Pacific

        12.2.2. By Product and Service

        12.2.3. By Technology

        12.2.4. By End Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product and Service

        12.3.3. By Technology

        12.3.4. By End Use

    12.4. Key Takeaways

13. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of Middle East and Africa

        13.2.2. By Product and Service

        13.2.3. By Technology

        13.2.4. By End Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product and Service

        13.3.3. By Technology

        13.3.4. By End Use

    13.4. Key Takeaways

14. Key Countries Market Analysis

    14.1. USA

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2022

            14.1.2.1. By Product and Service

            14.1.2.2. By Technology

            14.1.2.3. By End Use

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2022

            14.2.2.1. By Product and Service

            14.2.2.2. By Technology

            14.2.2.3. By End Use

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2022

            14.3.2.1. By Product and Service

            14.3.2.2. By Technology

            14.3.2.3. By End Use

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2022

            14.4.2.1. By Product and Service

            14.4.2.2. By Technology

            14.4.2.3. By End Use

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2022

            14.5.2.1. By Product and Service

            14.5.2.2. By Technology

            14.5.2.3. By End Use

    14.6. United Kingdom

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2022

            14.6.2.1. By Product and Service

            14.6.2.2. By Technology

            14.6.2.3. By End Use

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2022

            14.7.2.1. By Product and Service

            14.7.2.2. By Technology

            14.7.2.3. By End Use

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2022

            14.8.2.1. By Product and Service

            14.8.2.2. By Technology

            14.8.2.3. By End Use

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2022

            14.9.2.1. By Product and Service

            14.9.2.2. By Technology

            14.9.2.3. By End Use

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2022

            14.10.2.1. By Product and Service

            14.10.2.2. By Technology

            14.10.2.3. By End Use

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2022

            14.11.2.1. By Product and Service

            14.11.2.2. By Technology

            14.11.2.3. By End Use

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2022

            14.12.2.1. By Product and Service

            14.12.2.2. By Technology

            14.12.2.3. By End Use

    14.13. Thailand

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2022

            14.13.2.1. By Product and Service

            14.13.2.2. By Technology

            14.13.2.3. By End Use

    14.14. Singapore

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2022

            14.14.2.1. By Product and Service

            14.14.2.2. By Technology

            14.14.2.3. By End Use

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2022

            14.15.2.1. By Product and Service

            14.15.2.2. By Technology

            14.15.2.3. By End Use

    14.16. GCC Countries

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2022

            14.16.2.1. By Product and Service

            14.16.2.2. By Technology

            14.16.2.3. By End Use

    14.17. South Africa

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2022

            14.17.2.1. By Product and Service

            14.17.2.2. By Technology

            14.17.2.3. By End Use

    14.18. Israel

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2022

            14.18.2.1. By Product and Service

            14.18.2.2. By Technology

            14.18.2.3. By End Use

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Product and Service

        15.3.3. By Technology

        15.3.4. By End Use

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. GenScript Biotech Corporation

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Bachem Holding AG

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Thermo Fisher Scientific Inc.

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Merck KGaA

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. Kaneka Corporation

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Biotage AB

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. Syngene International Limited

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. Mesa Laboratories, Inc.

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Cem Corporation

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Proteogenix

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 4: Global Market Value (US$ Million) Forecast by End Use , 2017 to 2033

Table 5: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 8: North America Market Value (US$ Million) Forecast by End Use , 2017 to 2033

Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 10: Latin America Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by End Use , 2017 to 2033

Table 13: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 14: Europe Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033

Table 15: Europe Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by End Use , 2017 to 2033

Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 18: Asia Pacific Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033

Table 19: Asia Pacific Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 20: Asia Pacific Market Value (US$ Million) Forecast by End Use , 2017 to 2033

Table 21: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Product and Service, 2017 to 2033

Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2017 to 2033

Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End Use , 2017 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Technology, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by End Use , 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 5: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033

Figure 9: Global Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 10: Global Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 11: Global Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 12: Global Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 13: Global Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 14: Global Market Value (US$ Million) Analysis by End Use , 2017 to 2033

Figure 15: Global Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033

Figure 16: Global Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033

Figure 17: Global Market Attractiveness by Product and Service, 2023 to 2033

Figure 18: Global Market Attractiveness by Technology, 2023 to 2033

Figure 19: Global Market Attractiveness by End Use , 2023 to 2033

Figure 20: Global Market Attractiveness by Region, 2023 to 2033

Figure 21: North America Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 22: North America Market Value (US$ Million) by Technology, 2023 to 2033

Figure 23: North America Market Value (US$ Million) by End Use , 2023 to 2033

Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 25: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 28: North America Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033

Figure 29: North America Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 30: North America Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by End Use , 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033

Figure 37: North America Market Attractiveness by Product and Service, 2023 to 2033

Figure 38: North America Market Attractiveness by Technology, 2023 to 2033

Figure 39: North America Market Attractiveness by End Use , 2023 to 2033

Figure 40: North America Market Attractiveness by Country, 2023 to 2033

Figure 41: Latin America Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 42: Latin America Market Value (US$ Million) by Technology, 2023 to 2033

Figure 43: Latin America Market Value (US$ Million) by End Use , 2023 to 2033

Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 48: Latin America Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) Analysis by End Use , 2017 to 2033

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033

Figure 57: Latin America Market Attractiveness by Product and Service, 2023 to 2033

Figure 58: Latin America Market Attractiveness by Technology, 2023 to 2033

Figure 59: Latin America Market Attractiveness by End Use , 2023 to 2033

Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 61: Europe Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 62: Europe Market Value (US$ Million) by Technology, 2023 to 2033

Figure 63: Europe Market Value (US$ Million) by End Use , 2023 to 2033

Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 68: Europe Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033

Figure 69: Europe Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 71: Europe Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 72: Europe Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 74: Europe Market Value (US$ Million) Analysis by End Use , 2017 to 2033

Figure 75: Europe Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033

Figure 77: Europe Market Attractiveness by Product and Service, 2023 to 2033

Figure 78: Europe Market Attractiveness by Technology, 2023 to 2033

Figure 79: Europe Market Attractiveness by End Use , 2023 to 2033

Figure 80: Europe Market Attractiveness by Country, 2023 to 2033

Figure 81: Asia Pacific Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 82: Asia Pacific Market Value (US$ Million) by Technology, 2023 to 2033

Figure 83: Asia Pacific Market Value (US$ Million) by End Use , 2023 to 2033

Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033

Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End Use , 2017 to 2033

Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033

Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033

Figure 97: Asia Pacific Market Attractiveness by Product and Service, 2023 to 2033

Figure 98: Asia Pacific Market Attractiveness by Technology, 2023 to 2033

Figure 99: Asia Pacific Market Attractiveness by End Use , 2023 to 2033

Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033

Figure 101: Middle East and Africa Market Value (US$ Million) by Product and Service, 2023 to 2033

Figure 102: Middle East and Africa Market Value (US$ Million) by Technology, 2023 to 2033

Figure 103: Middle East and Africa Market Value (US$ Million) by End Use , 2023 to 2033

Figure 104: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 105: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 106: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 107: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 108: Middle East and Africa Market Value (US$ Million) Analysis by Product and Service, 2017 to 2033

Figure 109: Middle East and Africa Market Value Share (%) and BPS Analysis by Product and Service, 2023 to 2033

Figure 110: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product and Service, 2023 to 2033

Figure 111: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2017 to 2033

Figure 112: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033

Figure 113: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033

Figure 114: Middle East and Africa Market Value (US$ Million) Analysis by End Use , 2017 to 2033

Figure 115: Middle East and Africa Market Value Share (%) and BPS Analysis by End Use , 2023 to 2033

Figure 116: Middle East and Africa Market Y-o-Y Growth (%) Projections by End Use , 2023 to 2033

Figure 117: Middle East and Africa Market Attractiveness by Product and Service, 2023 to 2033

Figure 118: Middle East and Africa Market Attractiveness by Technology, 2023 to 2033

Figure 119: Middle East and Africa Market Attractiveness by End Use , 2023 to 2033

Figure 120: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Peptide Therapeutics Market

Published : January 2023

Explore Healthcare Insights

View Reports